News & Updates

Show Multimedia Only

Anxiety in high-risk pregnancy ups risk of arterial stiffness, pre-eclampsia

21 Aug 2025

Women with high-risk pregnancies who have anxiety are at increased risk of arterial stiffness and, potentially, pre-eclampsia, as suggested in a study.

Anxiety in high-risk pregnancy ups risk of arterial stiffness, pre-eclampsia

21 Aug 2025

Preventive fremanezumab sustains reductions in migraine days up to 2 years in real world

21 Aug 2025 by

In the final analysis of the real-world PEARL study presented at EAN 2025, fremanezumab as a preventive treatment for chronic or episodic migraine halves the number of monthly migraine days or more from 3 months onwards through 24 months

Preventive fremanezumab sustains reductions in migraine days up to 2 years in real world

21 Aug 2025

Novel selective OX2R antagonist works well for people with insomnia

20 Aug 2025 by

The novel selective orexin-2 receptor (OX2R) antagonist seltorexant helped promote sleep in people with insomnia, with the efficacy maintained over a 2-week treatment period, according to a phase 2b study.

Novel selective OX2R antagonist works well for people with insomnia

20 Aug 2025

Fenestrated outdoes conventional silicone stents in benign central airway stenosis

20 Aug 2025

The use of fenestrated stents results in longer patency, fewer complications, and improved biomechanical performance than conventional silicone stents, without compromising the structural integrity of the stent, according to a study.

Fenestrated outdoes conventional silicone stents in benign central airway stenosis

20 Aug 2025

Mizagliflozin improves postprandial glucose in postbariatric hypoglycaemia

20 Aug 2025 by

Patients with postbariatric hypoglycaemia (PBH) may benefit from using mizagliflozin, which contributes to significant reductions in hypoglycaemic events, reports a study presented at ENDO 2025.

Mizagliflozin improves postprandial glucose in postbariatric hypoglycaemia

20 Aug 2025

Setmelanotide lowers BMI in patients with hypothalamic obesity

20 Aug 2025 by

Treatment with setmelanotide results in significant BMI reductions in individuals with acquired hypothalamic obesity compared with placebo, with an acceptable safety profile, as shown by the results of a phase III study presented at ENDO 2025.

Setmelanotide lowers BMI in patients with hypothalamic obesity

20 Aug 2025

CSP vs BVP: Which one is better for HFrEF with non-LBBB?

20 Aug 2025 by

In a meta-analysis comparing procedural and clinical outcomes between conduction system pacing (CSP) and biventricular cardiac resynchronization pacing (BVP), the former appears to outdo the latter for managing individuals with heart failure with reduced ejection fraction (HFrEF) without left bundle branch block (LBBB).

CSP vs BVP: Which one is better for HFrEF with non-LBBB?

20 Aug 2025

Rivaroxaban curbs MACE, major bleeding risks in AF patients with CAD, regardless of age

20 Aug 2025

Monotherapy with rivaroxaban in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) appears to protect against the risks of major adverse cardiovascular event (MACE) and major bleeding, with the benefit observed across the broad range of age, according to a post hoc analysis of the open-label AFIRE* trial.

Rivaroxaban curbs MACE, major bleeding risks in AF patients with CAD, regardless of age

20 Aug 2025

Smoking cessation experts from New Zealand and Malaysia come together to give their thoughts on the recent vape issues.

20 Aug 2025

Vape or e-cigarette is a rather recent arrival in the nicotine delivery route. As such, little is known about the long-term effects of vaping. However, developments in recent years have brought vaping to the limelight as it is becoming increasingly obvious that the vape industry is targeting youth. Initially unintentional, but increasingly deliberate as it became obvious that youth were a valuable source of current and future income.

Smoking cessation experts from New Zealand and Malaysia come together to give their thoughts on the recent vape issues.

20 Aug 2025

Dr Chan Wah Keong gives an overview of diabetes and fatty liver diseas

20 Aug 2025 by

At the recent Diabetes Malaysia Conference 2025, Professor Dr Chan Wah Keong, a consultant gastroenterologist and hepatologist, gave an overview of fatty liver disease. Chan, from Universiti Malaya Medical Centre, covered topics such as nomenclature of fatty liver disease, its impact in Malaysia, management strategies and emerging treatments.

Dr Chan Wah Keong gives an overview of diabetes and fatty liver diseas

20 Aug 2025

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Anxiety in high-risk pregnancy ups risk of arterial stiffness, pre-eclampsia

Anxiety in high-risk pregnancy ups risk of arterial stiffness, pre-eclampsia

Preventive fremanezumab sustains reductions in migraine days up to 2 years in real world

Preventive fremanezumab sustains reductions in migraine days up to 2 years in real world

Novel selective OX2R antagonist works well for people with insomnia

Novel selective OX2R antagonist works well for people with insomnia

Fenestrated outdoes conventional silicone stents in benign central airway stenosis

Fenestrated outdoes conventional silicone stents in benign central airway stenosis

Mizagliflozin improves postprandial glucose in postbariatric hypoglycaemia

Mizagliflozin improves postprandial glucose in postbariatric hypoglycaemia

Setmelanotide lowers BMI in patients with hypothalamic obesity

Setmelanotide lowers BMI in patients with hypothalamic obesity

CSP vs BVP: Which one is better for HFrEF with non-LBBB?

CSP vs BVP: Which one is better for HFrEF with non-LBBB?

Rivaroxaban curbs MACE, major bleeding risks in AF patients with CAD, regardless of age

Rivaroxaban curbs MACE, major bleeding risks in AF patients with CAD, regardless of age

Smoking cessation experts from New Zealand and Malaysia come together to give their thoughts on the recent vape issues.

Smoking cessation experts from New Zealand and Malaysia come together to give their thoughts on the recent vape issues.

Dr Chan Wah Keong gives an overview of diabetes and fatty liver diseas

Dr Chan Wah Keong gives an overview of diabetes and fatty liver diseas